by Combat Cancer | Jun 15, 2024 | News
Men’s Health Week 2024, running from 10th to 16th June, is a global initiative that occurs annually in the week leading up to and including Father’s Day. This important week aims to heighten awareness of preventable health issues and promote the early...
by Combat Cancer | Jun 8, 2024 | News
Combat Medical’s HIVEC® (recirculating hyperthermic intravesical chemotherapy) system, utilising mitomycin C (MMC), offers a compelling alternative to Bacillus Calmette-Guérin (BCG) for treating high-risk, non-muscle-invasive bladder cancer (NMIBC). As a...
by Combat Cancer | Jun 1, 2024 | News
New HIVEC®-HEAT Phase 3 trial for bladder cancer could be a game-changer forpatients with BCG-unresponsive nonmuscle-invasive bladder cancer Combat Medical has entered into partnership with the University of Leicester, England, to run aphase 3 trial of its HIVEC®...
by Combat Cancer | May 25, 2024 | News
Bladder cancer is the seventh most commonly diagnosed solid tumour worldwide, with around 75% of cases being non-muscle-invasive. Despite its prevalence, awareness about its signs and symptoms remains alarmingly low. A recent patient survey conducted by the World...
by Combat Cancer | May 23, 2024 | News
May 23 2024 – Combat Medical has entered into partnership with the University of Leicester, England, to run a phase 3 trial of its HIVEC® treatment for BCG-unresponsive nonmuscle-invasive bladder cancer (NMIBC) as an alternative to radical cystectomy. HIVEC®-HEAT...
Recent Comments